Hyperliquid Strategies (NASDAQ:PURR) Given Buy Rating at Chardan Capital

Hyperliquid Strategies (NASDAQ:PURR)‘s stock had its “buy” rating reissued by equities researchers at Chardan Capital in a report released on Friday,Benzinga reports. They currently have a $9.75 price target on the stock. Chardan Capital’s price objective suggests a potential upside of 11.29% from the company’s current price.

A number of other equities analysts have also issued reports on PURR. Weiss Ratings upgraded shares of Hyperliquid Strategies from a “sell (d)” rating to a “sell (d+)” rating in a research report on Wednesday, June 3rd. Maxim Group started coverage on shares of Hyperliquid Strategies in a research report on Friday, April 24th. They set a “buy” rating and a $10.00 target price on the stock. Wall Street Zen upgraded shares of Hyperliquid Strategies to a “hold” rating in a research report on Saturday, February 21st. Finally, Cantor Fitzgerald raised their target price on shares of Hyperliquid Strategies from $6.00 to $8.00 and gave the stock an “overweight” rating in a research report on Monday, May 11th. Three research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat, Hyperliquid Strategies presently has a consensus rating of “Moderate Buy” and a consensus price target of $9.25.

Hyperliquid Strategies Trading Up 3.2%

PURR stock traded up $0.27 during midday trading on Friday, reaching $8.76. 5,154,382 shares of the company were exchanged, compared to its average volume of 7,552,934. Hyperliquid Strategies has a 1-year low of $3.01 and a 1-year high of $11.62. The company’s 50-day moving average price is $7.07. The company has a market capitalization of $1.27 billion, a P/E ratio of -1.19 and a beta of 1.64.

Hyperliquid Strategies (NASDAQ:PURR) last announced its earnings results on Thursday, May 7th. The company reported $1.01 earnings per share (EPS) for the quarter. The business had revenue of $2.63 million for the quarter. As a group, sell-side analysts predict that Hyperliquid Strategies will post -0.75 EPS for the current year.

Institutional Investors Weigh In On Hyperliquid Strategies

Institutional investors have recently made changes to their positions in the stock. Boothbay Fund Management LLC acquired a new position in shares of Hyperliquid Strategies during the 4th quarter worth $40,000. XTX Topco Ltd acquired a new position in shares of Hyperliquid Strategies during the 4th quarter worth $48,000. Private Advisor Group LLC acquired a new position in shares of Hyperliquid Strategies during the 1st quarter worth $83,000. Squarepoint Ops LLC acquired a new position in shares of Hyperliquid Strategies during the 4th quarter worth $73,000. Finally, SG Americas Securities LLC acquired a new position in shares of Hyperliquid Strategies during the 1st quarter worth $117,000. 9.45% of the stock is currently owned by hedge funds and other institutional investors.

Hyperliquid Strategies Company Profile

Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc, is based in NEW YORK.